Literature DB >> 17044709

The conformation of cyclo(-D-Pro-Ala4-) as a model for cyclic pentapeptides of the DL4 type.

Markus Heller1, Martin Sukopp, Natia Tsomaia, Michael John, Dale F Mierke, Bernd Reif, Horst Kessler.   

Abstract

The conformation of the cyclic pentapeptide cyclo(-D-Pro-Ala(4)-) in solution and in the solid state was reinvestigated using modern NMR techniques. To allow unequivocal characterization of hydrogen bonds, relaxation behavior, and intramolecular distances, differently labeled isotopomers were synthesized. The NMR results, supported by extensive MD simulations, demonstrate unambiguously that the preferred conformation previously described by us, but recently questioned, is indeed correct. The validation of the conformational preferences of this cyclic peptide is important given that this system is a template for several bioactive compounds and for controlled "spatial screening" for the search of bioactive conformations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17044709     DOI: 10.1021/ja063174a

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  9 in total

1.  Design and synthesis of Hsp90 inhibitors: exploring the SAR of Sansalvamide A derivatives.

Authors:  Robert P Sellers; Leslie D Alexander; Victoria A Johnson; Chun-Chieh Lin; Jeremiah Savage; Ricardo Corral; Jason Moss; Tim S Slugocki; Erinprit K Singh; Melinda R Davis; Suchitra Ravula; Jamie E Spicer; Jenna L Oelrich; Andrea Thornquist; Chung-Mao Pan; Shelli R McAlpine
Journal:  Bioorg Med Chem       Date:  2010-07-22       Impact factor: 3.641

2.  Synthesis of sansalvamide A peptidomimetics: triazole, oxazole, thiazole, and pseudoproline containing compounds.

Authors:  Melinda R Davis; Erinprit K Singh; Hendra Wahyudi; Leslie D Alexander; Joseph B Kunicki; Lidia A Nazarova; Kelly A Fairweather; Andrew M Giltrap; Katrina A Jolliffe; Shelli R McAlpine
Journal:  Tetrahedron       Date:  2012-01-28       Impact factor: 2.457

3.  Design of a conformationally defined and proteolytically stable circular mimetic of brain-derived neurotrophic factor.

Authors:  Jordan M Fletcher; Craig J Morton; Richard A Zwar; Simon S Murray; Paul D O'Leary; Richard A Hughes
Journal:  J Biol Chem       Date:  2008-09-22       Impact factor: 5.157

Review 4.  Understanding and designing head-to-tail cyclic peptides.

Authors:  Diana P Slough; Sean M McHugh; Yu-Shan Lin
Journal:  Biopolymers       Date:  2018-03-12       Impact factor: 2.505

5.  Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies.

Authors:  Lucas Doedens; Florian Opperer; Minying Cai; Johannes G Beck; Matt Dedek; Erin Palmer; Victor J Hruby; Horst Kessler
Journal:  J Am Chem Soc       Date:  2010-06-16       Impact factor: 15.419

6.  Evaluation of di-sansalvamide A derivatives: synthesis, structure-activity relationship, and mechanism of action.

Authors:  Leslie D Alexander; Robert P Sellers; Melinda R Davis; Veronica C Ardi; Victoria A Johnson; Robert C Vasko; Shelli R McAlpine
Journal:  J Med Chem       Date:  2009-12-24       Impact factor: 7.446

7.  A comprehensive study of Sansalvamide A derivatives: The structure-activity relationships of 78 derivatives in two pancreatic cancer cell lines.

Authors:  Po-Shen Pan; Robert C Vasko; Stephanie A Lapera; Victoria A Johnson; Robert P Sellers; Chun-Chieh Lin; Chung-Mao Pan; Melinda R Davis; Veronica C Ardi; Shelli R McAlpine
Journal:  Bioorg Med Chem       Date:  2009-07-15       Impact factor: 3.641

8.  Exploring the Energy Landscapes of Cyclic Tetrapeptides with Discrete Path Sampling.

Authors:  Mark T Oakley; Roy L Johnston
Journal:  J Chem Theory Comput       Date:  2012-11-05       Impact factor: 6.006

9.  The influence of solvent on conformational properties of peptides with Aib residue-a DFT study.

Authors:  Roksana Wałęsa; Małgorzata A Broda
Journal:  J Mol Model       Date:  2017-11-21       Impact factor: 1.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.